MEXICO-USA-CANADA HEALTH FRAUD TASK
Whereas, health fraud is a critical problem which can induce death or serious injury and which can cause consumers with serious medical problems to delay or discontinue appropriate medical treatment; and
Whereas, health fraud often results in consumers wasting large sums of money on useless, unproved, deceptively advertised and marketed products, treatments and/or devices; and
Whereas, cross-border health fraud has become a serious problem, where fraudulent health products and treatments that originate in one country are marketed to residents of another country; and
Whereas, cross-border health fraud is a particular problem for residents living near the Mexico-United States-Canada borders; and
Whereas, for the past several years a Mexico-USA-Canada Health Fraud Task Force ("Task Force"), including officials from the U.S. Food and Drug Administration, the Federal Trade Commission's Bureau of Consumer Protection, and members of the National Association of Attorneys General, representing the United States; the Secretaria de Salud and the Procuraduria Federal del Consumidor, representing Mexico; and the Therapeutic Products Program of Health Canada and the Competition Bureau of Industry Canada, has been meeting semi-annually to exchange ideas and information.
Now therefore, in order to establish a more formal framework for continuing and broadening such cooperation and to build on the success of the Task Force in identifying and addressing health fraud issues of mutual concern, the member agencies of the Task Force listed below hereby adopt the following joint strategies to combat health fraud:
To the extent compatible with their laws, enforcement policies and other important interests, each agency intends to: